Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2004;53:478-479; doi:10.1136/gut.2003.030312
Copyright © 2004 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 2004;53:478-479
© 2004 by BMJ Publishing Group Ltd & British Society of Gastroenterology

COMMENTARY

Cancer

Gene transfer: Bax to the future for cancer therapy

N R Lemoine, I A McNeish

Cancer Research UK Clinical Centre, Sir John Vane Science Building, Barts and the London School of Medicine and Dentistry, London, UK

Correspondence to:
Correspondence to:
Professor N R Lemoine
Cancer Research UK Clinical Centre, Sir John Vane Science Building, Barts and the London School of Medicine and Dentistry, Charterhouse Sq, London EC1M 6BQ, UK; nick.lemoine@cancer.org.uk


The Bax gene as a competitor in the marathon towards licensed cancer gene therapy

The first 150 words of the full text of this article appear below.

Intraperitoneal spread of gastrointestinal malignancies is a significant clinical problem and contributes to an incidence of distant relapse as high as 30% in gastric cancer. Local dissemination of tumour cells into the peritoneal cavity determines the outcome in advanced gastric cancer and diffuse-type carcinoma, and patients with negative peritoneal washings have a more favourable prognosis. Extensive lymph node dissection has been shown (by quantitative reverse transcription-polymerase chain reaction for carcinoembryonic antigen and cytokeratin 20 combined with extensive intraoperative peritoneal lavage1) to open lymphatic channels and spread viable cancer cells into the peritoneal cavity. Hence patient subpopulations that might benefit from intraperitoneal therapy regimens may be identified.

Malignant disease localised within the abdominal cavity has been a target for the staged development of clinical gene therapy approaches because of the smaller doses of experimental agent and increased safety margins over systemic administration. There has been extensive—and safe—experience of p53 . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer
Y Tsunemitsu, S Kagawa, N Tokunaga, S Otani, T Umeoka, J A Roth, B Fang, N Tanaka, and T Fujiwara
Gut 2004 53: 554-560. [Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Gene transfer in cancer therapy
Jannis Kountouras, et al.
Gut Online, 7 Apr 2004 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs